Главная
Рынки
Графики и идеи
Алготрейдинг
Новости
Store
Брокеры
Скачать
Экономический календарь
Торговые сигналы
Вебтерминал
Нажмите
/
для поиска: @user, $symbol, ...
Поиск
Вход
Создать аккаунт
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
OSUR
#2938
OraSure Technologies Inc
3.1
5
+1.94%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
Годовой диапазон
Дневное изменение
+1.94%
Месячное изменение
+16.24%
6-месячное изменение
-5.69%
Годовое изменение
-6.80%
Предыдущее закрытие
3.0
9
Open
3.1
5
Bid
Ask
Low
3.1
5
High
3.1
5
Объем
50
Рынки
Рынок акций США
Здравоохранение
OSUR
Open full chart
Financials
Overview
Отчетность
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Total assets
464.08 M
479.66 M
457.61 M
445.04 M
423.1 M
Total liabilities
38.52 M
69.32 M
61.33 M
64.31 M
61.12 M
Total equity
425.56 M
410.34 M
396.28 M
380.72 M
361.98 M
Total liabilities & shareholders' equities
464.08 M
479.66 M
457.61 M
445.04 M
423.1 M
Total debt
—
—
—
—
—
Net debt
—
—
—
—
—
OraSure Technologies Inc
OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test.
Новости
OraSure Technologies, Inc. (OSUR) Q4 2025 Earnings Call Transcript
Lucro da OraSure veio em linha com as projeções; receita menor do que estimativas
OraSure earnings matched, revenue fell short of estimates
OraSure’s HIV self-test receives Health Canada license
Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates
Altai Capital nomeia dois diretores para o conselho da OraSure Technologies
Altai Capital nominates two directors for OraSure Technologies board
Altai Capital nomeia dois diretores para o conselho da OraSure em meio a preocupações
Altai Capital nominates two directors to OraSure board amid concerns
OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device
OraSure submits FDA applications for rapid STI test and collection device
Altai Capital indicará dois candidatos para o conselho da OraSure Technologies